How many insider declarations has Goodman, Jonathan Ross filed?

Goodman, Jonathan Ross has filed 2 public insider declarations with SEDI.

What is Goodman, Jonathan Ross's role?

Goodman, Jonathan Ross's reported role is not specified by the regulator across the filings.

Which companies does Goodman, Jonathan Ross report trades for?

Goodman, Jonathan Ross reports trades for Knight Therapeutics Inc..

What is Goodman, Jonathan Ross's declared buy vs sell volume?

Across the available history, declared buys total 5k€ and disposals 0.

← Executives ★ Sign in to follow

GJ

Goodman, Jonathan Ross

OWNER 10PCT

·SEDI

Knight Therapeutics Inc.

0

申报总数

0

公司

€5,006

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the detailed record of transactions filed by Goodman, Jonathan Ross. Insider active across 1 company, notably Knight Therapeutics Inc.. Cumulatively, 2 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 June 2026. The latest transaction was filed on 15 June 2026 (30 - Acquisition or disposition under a purchase/ownership plan). Regulator: SEDI. All data is accessible without signup.

Companies and markets linked to Goodman, Jonathan Ross

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Knight Therapeutics Inc. (CA)

申报2 总计

▲

Goodman, Jonathan Ross

4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder高管2026年6月15日Knight Therapeutics Inc.

CA$1,39442SEDI ↗

267 股@ CA$5.220.0001% mcap17.2% 占其流量Common SharesTSXSEDI:4736907

标准退出：2026年9月13日 (T+90)

▲

Goodman, Jonathan Ross

4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder高管2026年6月15日Knight Therapeutics Inc.

CA$6,72048SEDI ↗

718 股@ CA$9.360.0007% mcap82.8% 占其流量Common SharesTSXSEDI:4736906

标准退出：2026年9月13日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

GJ

Goodman, Jonathan Ross

OWNER 10PCT

·SEDI

Knight Therapeutics Inc.

0

申报总数

0

公司

€5,006

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the detailed record of transactions filed by Goodman, Jonathan Ross. Insider active across 1 company, notably Knight Therapeutics Inc.. Cumulatively, 2 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 June 2026. The latest transaction was filed on 15 June 2026 (30 - Acquisition or disposition under a purchase/ownership plan). Regulator: SEDI. All data is accessible without signup.

Companies and markets linked to Goodman, Jonathan Ross

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Knight Therapeutics Inc. (CA)

申报2 总计

▲

Goodman, Jonathan Ross

4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder高管2026年6月15日Knight Therapeutics Inc.

CA$1,39442SEDI ↗

267 股@ CA$5.220.0001% mcap17.2% 占其流量Common SharesTSXSEDI:4736907

标准退出：2026年9月13日 (T+90)

▲

Goodman, Jonathan Ross

4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder高管2026年6月15日Knight Therapeutics Inc.

CA$6,72048SEDI ↗

718 股@ CA$9.360.0007% mcap82.8% 占其流量Common SharesTSXSEDI:4736906

标准退出：2026年9月13日 (T+90)

2 条申报中的 2 条

Goodman, Jonathan Ross

内部人交易记录

Companies and markets linked to Goodman, Jonathan Ross

Related entities

Goodman, Jonathan Ross

内部人交易记录

Companies and markets linked to Goodman, Jonathan Ross

Related entities